BIOMERIEUX (P.S.) O.N./ FR0013280286 /
| 2024-11-08 2:33:15 PM | Chg. -0.40 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 101.30EUR | -0.39% | 29 Turnover: 2,935.60 |
102.30Bid Size: 11 | 102.80Ask Size: 11 | 12.11 bill.EUR | 0.83% | 33.76 |
Assets
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 807.5000 | 894.7000 | 939 | 1,224.8000 | 1,369.9000 | ||||||
| Intangible Assets | 507.3000 | 508.4000 | 430.7000 | 411.5000 | 625 | ||||||
| Long-Term Investments | 71.8000 | 41.9000 | 50.6000 | - | - | ||||||
| Fixed Assets | 2,093.9000 | 2,343.5000 | 2,266.3000 | 2,412.5000 | 2,969.9000 | ||||||
| Inventories | 414.9000 | 494.7000 | 541.9000 | 620 | 737.2000 | ||||||
| Accounts Receivable | 490 | 552.1000 | 597.9000 | 590.6000 | 740.1000 | ||||||
| Cash and Cash Equivalents | 280.1000 | 275 | 389.2000 | 803.5000 | 552.6000 | ||||||
| Current Assets | 1,295.6000 | 1,438.5000 | 1,661.6000 | 2,184.6000 | 2,216.7000 | ||||||
| Total Assets | 3,389.6000 | 3,781.9000 | 3,927.8000 | 4,605 | 5,186.6000 | ||||||
Liabilities
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 176.9000 | 211.9000 | 207.1000 | 239.5000 | 269.4000 | ||||||
| Long-term debt | 446.8000 | 153.7000 | 352.4000 | 362.8000 | 318.4000 | ||||||
| Liabilities to Banks | 547 | 592.3000 | 481.3000 | - | - | ||||||
| Provisions | 136 | 141.2000 | 105.8000 | 174.3000 | 136.2000 | ||||||
| Liabilities | 1,386.3000 | 1,527.3000 | 1,446.5000 | 1,441.4000 | 1,543.6000 | ||||||
| Share Capital | 12 | 12 | 12 | - | - | ||||||
| Total Equity | 1,929.3000 | 2,203.9000 | 2,431.1000 | 3,163.6000 | 3,643 | ||||||
| Minority Interests | 74 | 50.7000 | 50.2000 | - | - | ||||||
| Total liabilities equity | 3,389.6000 | 3,781.9000 | 3,927.8000 | 4,605 | 5,186.6000 | ||||||
Income Statement
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,421.3000 | 2,674.8000 | 3,118.2000 | 3,376.2000 | 3,589.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 343.6000 | 370.7000 | 595.1000 | 784.3000 | 587.2000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 320.8000 | 347.5000 | 524.4000 | - | - | ||||||
| Income Taxes | -65.2000 | -77.8000 | -121.7000 | 175.6000 | 140.1000 | ||||||
| Minority Interests Profit | 1.1000 | 3.1000 | 1.7000 | 2.9000 | 11.8000 | ||||||
| Net Income | 256.6000 | 272.8000 | 404.4000 | 601.1000 | 452.4000 | ||||||
Per Share
Cash Flow
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 386.9000 | 407.9000 | 582.8000 | 824.7000 | 475.1000 | ||||||
| Cash Flow from Investing Activities | -418.2000 | -282.2000 | -265.2000 | -307.3000 | -528.1000 | ||||||
| Cash Flow from Financing | 52.7000 | -133.9000 | -176.2000 | -140.6000 | -244.2000 | ||||||
| Decrease / Increase in Cash | 21.4000 | -8.2000 | 141.4000 | - | - | ||||||
| Employees | 11,029 | 12,000 | 13,000 | 12,379 | 13,135 | ||||||
